Oxford vaccine found safe and immunogenic even in older adults
The results were published online in The Lancet on November 19. The results are based on the study of 560
Read MoreThe results were published online in The Lancet on November 19. The results are based on the study of 560
Read MoreOn November 18, Pfizer announced that the final efficacy analysis of its candidate mRNA-based vaccine (BNT162b2) in phase-3 trial has
Read MoreThe interim results of Moderna’s mRNA vaccine show that the vaccine has 94.5% efficacy in preventing COVID-19. The interim analysis,
Read More